Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.
Historically, GFR equations, which predict the measured GFR (mGFR), were developed on patients with native kidneys and were further validated and used in kidney recipients. However, studies have shown significant heterogeneity in the performances of GFR equations when applied in kidney recipients, which may be attributed to variations and intrinsic characteristics specific to the transplant population. We thus made the hypothesis that GFR equations developed on a large, well-phenotyped kidney recipient cohort might achieve good performances in predicting mGFR. The project therefore aims to: 1. Develop new kidney-recipient-specific (KRS) GFR equations and compare their performances with the standard GFR equations 2. Investigate whether the use of race increasers the performances of the new kidney-recipient-specific (KRS) GFR equations 3. Evaluate the effects of the new equations on the chronic kidney disease (CKD) prevalence and GFR stage This study will provide us with data of kidney transplant patients that may allow the development of a new KRS GFR equation. A new KRS GFR equation that presents with increased performances, as compared to current GFR equations, will improve the GFR calculation in kidney recipients, and therefore improve clinical decisions and the long-term kidney allograft management. Decisions regarding the return to dialysis or placement on the transplant waiting list will be taken with more accuracy and therefore potentially improve the financial allocation of kidney transplantation for the society.
Study Type
OBSERVATIONAL
Enrollment
11,412
Kidney recipients aged over 18 and of all sexes recruited from 2000 who have mGFR follow-up and clinical, biological, and immunological data
William J. von Liebig Centre for Transplantation and Clinical Regeneration, Mayo Clinic
Rochester, Minnesota, United States
Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, School of Medicine, University of Zagreb
Zagreb, Croatia
Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon
Lyon, France
Department of Nephrology, Centre Hospitalier Universitaire, Montpellier
Montpellier, France
Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Kidney Transplant Department, Tenon Hospital, Assistance Publique - Hôpitaux de Paris
Paris, France
Nephrology, Dialysis and Renal Transplantation Department, Hôpital Nord, CHU de Saint-Etienne, Jean Monnet University, Université de Lyon
Saint-Etienne, France
Department of Nephrology and Organ Transplantation, CHU Rangueil
Toulouse, France
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Bergamo, Italy
Measured glomerular filtration rate (mGFR)
Isotopic measurements of GFR
Time frame: Up to 15 years after kidney transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.